Poland· PL-100102520
Cerutin
A rutosid, kombinationen product containing acidum ascorbicum + rutosidum trihydricum, registered in Poland by Polfarmex S.A.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rutosid, kombinationen is registered in 3 of 19 countries.
Countries holding a registration under ATC C05CA51 (rutosid, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Rutosid, kombinationen · ATC C05CA51
3 / 19 countries
- Czechiaprice
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Acidum ascorbicum + Rutosidum trihydricum
- Manufacturer
- Polfarmex S.A.
- Country
- Poland (PL)
- ATC code
- C05CA51
- ATC class
- Rutosid, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909990882816
- gtin05909990882823
- gtin05909990882830
- gtin05909990882847
- gtin05909990422630
- gtin05909990422623
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C05CA51
Rutosid, kombinationen, as other registers publish it.
- CzechiaASCORUTINZentiva a.s., Bratislava
- CzechiaASCORUTINZentiva a.s., Bratislava
- CzechiaASCORUTINZentiva a.s., Bratislava
- CzechiaCYCLO 3 FORTPIERRE FABRE MEDICAMENT, Lavaur
- CzechiaCYCLO 3 FORTPIERRE FABRE MEDICAMENT, Lavaur
- CzechiaCYCLO 3 FORTPIERRE FABRE MEDICAMENT, Lavaur
- PolandRutinoscorbinHaleon Poland Sp. z o.o.
- NetherlandsVenoruton tabletten 500Healthypharm B.V.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Hungary · Ruta-C
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a7620674-64f5-4aba-8424-3130d45f8b7f GET /v1/drugs/a7620674-64f5-4aba-8424-3130d45f8b7f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "100 mg + 25 mg",
"packaging": "05909990882816 ¦ OTC ¦ 17708\n25 tabl.\n05909990882823 ¦ OTC ¦ 17709\n100 tabl.\n05909990882830 ¦ OTC ¦ Skasowane ¦ 17710\n25 tabl. w fiolce\n05909990882847 ¦ OTC ¦ Skasowane ¦ 17711\n100 tabl. w fiolce\n05909990422630 ¦ OTC ¦ 32734\n150 tabl.\n05909990422623 ¦ OTC ¦ 47369\n125 tabl.",
"substance": "Acidum ascorbicum 100 mg + Rutosidum trihydricum 25 mg",
"common_name": "Acidum ascorbicum + Rutosidum trihydricum",
"pl_product_id": "100102520",
"pozwolenie_nr": "08828",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about rutosid, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.